Literature DB >> 19644694

Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy.

Marcos Gelos1, Dariush Hinderberger, Ellen Welsing, Julia Belting, Kerstin Schnurr, Benno Mann.   

Abstract

INTRODUCTION: In colorectal cancer (CRC), no biological marker is known that could serve both as a marker for detection and prognosis. Electron spin resonance (ESR) spectroscopy of spin-labeled fatty acid (FA) molecules binding to human serum albumin is a suitable method for the detection of conformational changes and alterations of transport function of albumin through changes in its FA binding capabilities.
OBJECTIVE: The aim of this study was to examine whether the FA binding to albumin is detectably and significantly altered in CRC patients when compared with patients having benign colorectal diseases.
MATERIALS AND METHODS: One hundred four patients operatively or endoscopically treated for CRC, sigmoid diverticulitis, or a colorectal adenoma were examined before procedure. Albumin was analyzed by ESR with spin-labeled FA. A determination ratio (DR) was calculated from the measured ESR spectra as ratios of the fraction of FA that is tightly bound vs. the fractions that are loosely interacting with albumin or are unbound. RESULTS AND DISCUSSIONS: Patients with CRC showed significantly lower DR values (DR, -0.09 +/- 0.98 vs. 0.61 +/- 1.43) than patients with benign colorectal diseases, consistent with a change of conformation and transport function of albumin in CRC. Within the CRC group, with advanced tumor stage, the difference in DR values increased. ESR of FA binding to albumin thus seems to be suitable for detection of patients with CRC. Furthermore, a correlation with advanced tumor stage can be established.
CONCLUSIONS: These results suggest that a further evaluation of the role of ESR in patients with all stages of CRC should take place. It should also be examined whether ESR might play a role in detecting CRC in a larger panel of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644694     DOI: 10.1007/s00384-009-0777-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  18 in total

Review 1.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Authors:  Ulrich Kragh-Hansen; Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

2.  Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy.

Authors:  G Matthes; G Seibt; V Muravsky; G Hersmann; G Dornheim
Journal:  Transfus Apher Sci       Date:  2002-10       Impact factor: 1.764

3.  Clinical proteomics: written in blood.

Authors:  Lance A Liotta; Mauro Ferrari; Emanuel Petricoin
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

4.  Adjuvant therapy for colon cancer--the pace quickens.

Authors:  Carmen Allegra; Daniel J Sargent
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

5.  Conformation changes in albumin molecule as a marker of dissemination of the tumor process.

Authors:  A N Afanas'eva; V A Evtushenko
Journal:  Bull Exp Biol Med       Date:  2004-08       Impact factor: 0.804

6.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

7.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

8.  Cancer-associated alteration in fatty acid binding to albumin studied by spin-label electron spin resonance.

Authors:  Andrey Gurachevsky; Ekaterina Muravskaya; Tatjana Gurachevskaya; Lena Smirnova; Vladimir Muravsky
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

Review 9.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Authors:  M J Duffy; A van Dalen; C Haglund; L Hansson; E Holinski-Feder; R Klapdor; R Lamerz; P Peltomaki; C Sturgeon; O Topolcan
Journal:  Eur J Cancer       Date:  2007-05-18       Impact factor: 9.162

Review 10.  Blood markers for early detection of colorectal cancer: a systematic review.

Authors:  Sabrina Hundt; Ulrike Haug; Hermann Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

View more
  4 in total

1.  Spin electron paramagnetic resonance of albumin for diagnosis of oral squamous cell carcinoma (OSCC).

Authors:  Maximilian Moergel; Peer W Kämmerer; Kerstin Schnurr; Marcus O Klein; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2011-12-09       Impact factor: 3.573

2.  Maleimido-proxyl as an EPR spin label for the evaluation of conformational changes of albumin.

Authors:  Aleksandra Pavićević; Jinghui Luo; Ana Popović-Bijelić; Miloš Mojović
Journal:  Eur Biophys J       Date:  2017-09-23       Impact factor: 1.733

3.  Identification of Patients with Pancreatic Cancer by Electron Paramagnetic Resonance Spectroscopy of Fatty Acid Binding to Human Serum Albumin.

Authors:  Haleh H Haeri; Jörg Tomaszewski; Bettina Phytides; Heike Schimm; Gabriela Möslein; Marco Niedergethmann; Dariush Hinderberger; Marcos Gelos
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-02

4.  Changes in the electron paramagnetic resonance spectra of albumin-associated spin-labeled stearic acid as a diagnostic parameter of colorectal cancer.

Authors:  Zhongchao Liu; Wenyi Zhang; Saijun Fan; Liang Wang; Ling Jiao
Journal:  World J Surg Oncol       Date:  2013-09-11       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.